Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
25.23
-0.47 (-1.83%)
May 8, 2025, 10:57 AM - Market open

Janux Therapeutics Statistics

Total Valuation

JANX has a market cap or net worth of $1.49 billion. The enterprise value is $518.48 million.

Market Cap 1.49B
Enterprise Value 518.48M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, after market close.

Earnings Date May 20, 2025
Ex-Dividend Date n/a

Share Statistics

JANX has 59.17 million shares outstanding. The number of shares has increased by 22.12% in one year.

Current Share Class 59.17M
Shares Outstanding 59.17M
Shares Change (YoY) +22.12%
Shares Change (QoQ) +4.03%
Owned by Insiders (%) 6.63%
Owned by Institutions (%) 84.39%
Float 37.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 130.47
Forward PS 851.89
PB Ratio 1.48
P/TBV Ratio 1.49
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 48.97
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 59.21, with a Debt / Equity ratio of 0.02.

Current Ratio 59.21
Quick Ratio 59.03
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -10.09% and return on invested capital (ROIC) is -8.73%.

Return on Equity (ROE) -10.09%
Return on Assets (ROA) -8.57%
Return on Invested Capital (ROIC) -8.73%
Return on Capital Employed (ROCE) -9.47%
Revenue Per Employee $130,716
Profits Per Employee -$851,778
Employee Count 81
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.68% in the last 52 weeks. The beta is 3.24, so JANX's price volatility has been higher than the market average.

Beta (5Y) 3.24
52-Week Price Change -58.68%
50-Day Moving Average 29.81
200-Day Moving Average 42.97
Relative Strength Index (RSI) 36.48
Average Volume (20 Days) 1,067,363

Short Selling Information

The latest short interest is 9.34 million, so 15.79% of the outstanding shares have been sold short.

Short Interest 9.34M
Short Previous Month 10.10M
Short % of Shares Out 15.79%
Short % of Float 24.92%
Short Ratio (days to cover) 9.26

Income Statement

In the last 12 months, JANX had revenue of $10.59 million and -$68.99 million in losses. Loss per share was -$1.28.

Revenue 10.59M
Gross Profit -57.80M
Operating Income -98.85M
Pretax Income -44.05M
Net Income -68.99M
EBITDA -96.79M
EBIT -98.85M
Loss Per Share -$1.28
Full Income Statement

Balance Sheet

The company has $1.03 billion in cash and $23.03 million in debt, giving a net cash position of $1.00 billion or $16.94 per share.

Cash & Cash Equivalents 1.03B
Total Debt 23.03M
Net Cash 1.00B
Net Cash Per Share $16.94
Equity (Book Value) 1.02B
Book Value Per Share 17.32
Working Capital 1.02B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.81 million and capital expenditures -$359,000, giving a free cash flow of -$44.17 million.

Operating Cash Flow -43.81M
Capital Expenditures -359,000
Free Cash Flow -44.17M
FCF Per Share -$0.75
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -933.58%
Pretax Margin -651.62%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.12%
Shareholder Yield -22.12%
Earnings Yield -4.54%
FCF Yield -2.90%

Analyst Forecast

The average price target for JANX is $94.29, which is 273.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target $94.29
Price Target Difference 273.72%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 105.85%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

JANX has an Altman Z-Score of 34.14 and a Piotroski F-Score of 3.

Altman Z-Score 34.14
Piotroski F-Score 3